[1] |
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.Global,regional,and national incidence,prevalence,and years lived with disability for 354 diseases and injuries for 195 countries and territories,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2018,392(10 159):1789-1858.
|
[2] |
Zhou M,Wang H,Zeng X,et al.Mortality,morbidity,and risk factors in China and its provinces,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J].Lancet,2019,394(10 204):1145-1158.
|
[3] |
姜泊.胃肠病学[M].北京:人民卫生出版社,2015.
|
[4] |
中华医学会消化病学分会幽门螺杆菌和消化性溃疡学组.第五次全国幽门螺杆菌感染处理共识报告[J].中华内科杂志,2017,56(7):532.
|
[5] |
Tuteja AK,Talley NJ,Joos SK,et al.Abdominal bloating in employed adults:prevalence,risk factors,and association with other bowel disorders[J].Am J Gastroenterol,2008,103(5):1241-1248.
|
[6] |
邱冬妮,徐三荣,陈玉龙.要重视“腹胀”的诊断[J].中华诊断学电子杂志,2018,6(3):157-159.
|
[7] |
中华医学会消化病学分会.中国慢性胃炎共识意见(2017年,上海)[J].中华消化杂志,2017,37(11):670-683.
|
[8] |
Mikhail M,Crowley G,Haider SH,et al.Non-cardiac chest pain:A review of environmental exposure-associated comorbidities and biomarkers[J].EMJ Gastroenterol,2018,7(1):103-112.
|
[9] |
Tang B,Cai HD,Xie HL,et al.Epidemiology of globus symptoms and associated psychological factors in China[J].J Dig Dis,2016,17(5):319-324.
|
[10] |
李军祥,陈誩,李岩.功能性消化不良中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2017,25(12):889-894.
|
[11] |
Addendum to NICE guideline CG61,Irritable bowel syndrome in adults:Diagnosis and management of irritable bowel syndrome in primary care[M].London:National Institute for Health and Care Excellence(UK),2015.
|
[12] |
中华消化杂志编委会.消化性溃疡诊断与治疗规范(2016年,西安)[J].中华消化杂志,2016,36(8):508-513.
|
[13] |
Lee YY,Wu JCY.Management of patients with functional heartburn[J].Gastroenterology,2018,154(8):2018-2021.
|
[14] |
李军祥,柯晓.功能性便秘中西医结合诊疗共识意见(2017年)[J].中国中西医结合消化杂志,2018,4(1):18-26.
|
[15] |
Zhao YF,Guo XJ,Zhang ZS,et al.Epidemiology of functional diarrhea and comparison with diarrhea-predominant irritable bowel syndrome:a population-based survey in China[J].PLoS One,2012,7(8):e43749.
|
[19] |
Chen W,Sun K,Zheng R,et al.Cancer incidence and mortality in China,2014[J].Chin J Cancer,2018,30(1):1-35.
|
[21] |
孙淑娟,徐欣昌,田晓云.消化系统疾病[M].北京:人民卫生出版社,2015.
|
[22] |
李丹.消化系统疾病防治的认识与防控建议[J].中医药管理杂志,2016,24(5):158-159.
|
[23] |
鞠永红,方宗君,杨容.社区常见消化系统疾病患者不合理用药状况分析[J].临床合理用药杂志,2018,11(5A):113-114.
|
[24] |
王晓娣,董英.常见胃肠疾病与用药[J].中国药店,2001,(4):62-64.
|
[16] |
Fock KM,Talley N,Goh KL,et al.Asia-Pacific consensus on the management of gastro-oesophageal reflux disease:an update focusing on refractory reflux disease and Barrett′s oesophagus[J].Gut,2016,65(9):1402-1415.
|
[17] |
Bai JC,Fried M,Corazza GR,et al.World Gastroenterology Organisation global guidelines on celiac disease[J].J Clin Gastroenterol,2013,47(2):121-126.
|
[18] |
Yang L,Zhang R,Wang N,et al.Incidence and mortality of stomach cancer in China,2014[J].Chin J Cancer Res,2018,30(3):291-298.
|
[20] |
Ooi CJ,Makharia GK,Hilmi I,et al.The Asia Pacific Consensus Statements on Crohn′s Disease Part 1:definition,diagnosis and epidemiology[J].J Gastroenterol Hepatol,2016,31(1):45-55.
|
[25] |
王芬,刘文忠.幽门螺杆菌感染的危害和防控[J].疾病监测,2018,33(4):18-23.
|
[26] |
Johnson CH,McLean RC,McCallum I,et al.An evaluation of the epidemiology,management and outcomes for perforated peptic ulcers across the North of England over 15 years:A retrospective cohort study[J].Int J Surg,2019,64:24-32.
|
[27] |
刘文忠,谢勇,成虹.第四次全国幽门螺杆菌感染处理共识报告[J].胃肠病学,2012,17(10):358-363.
|
[28] |
谭建荣.消化性溃疡的病理生理学及治疗研究进展[J].吉林医学,2014,35(3):397-398.
|
[29] |
甘远,黄方华,王瑞云.幽门螺杆菌感染的治疗现状及进展[J].海南医学,2016,27(9):1483-1487.
|
[30] |
中华医学会老年医学分会.老年人功能性消化不良诊治专家共识[J].中华老年医学杂志,2015,34(3):1-7.
|
[31] |
金华.枸橼酸莫沙必利——新型胃动力药[J].药学进展,2000,24(5):306-308.
|
[32] |
许大波.新型促胃肠动力药物伊托必利[J].中国新药杂志,2002,11(6):437-439.
|
[33] |
张桂英.抑酸剂治疗酸相关疾病进展[J].中华消化杂志,2006,26(4):280-281.
|
[34] |
王世鑫.抑酸剂的现状与展望[J].中华消化内镜,2008,2(4):41-46.
|
[35] |
中华中医药学会脾胃病分会.慢性胃炎中医诊疗专家共识意见(2017)[J].中华中医药杂志,2017,32(7):3060-3064.
|
[36] |
Lundell L,Havu N,Miettinen P,et al.Changes of gastric mucosal architecture during long-term omeprazole therapy:results of a randomized clinical trial[J].Aliment Pharmacol Ther,2006,23(5):639-647.
|
[37] |
衣淑华,衣淑珍.质子泵抑制剂引发骨质疏松的病变机制和治疗策略[J].国际药学研究杂志,2012,7(1):61-64.
|
[38] |
陈敏,邹晓平.质子泵抑制剂基础与临床研究新进展[J].江苏医药,2012,38(5):580-582.
|
[39] |
Washio E,Esaki M,Maehata Y,et al.Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory druginduced small bowel injury:a randomized,placebo-controlled trial[J].Clin Gastroenterol Hepatol,2016,14(6):809-815.
|
[40] |
Yamada A,Niikura R,Maki K,et al.Proton pump inhibitor therapy did not increase the prevalence of small-bowel injury:A propensity-matched analysis[J].PLoS One,2017,12(8):e0182586.
|
[41] |
刘亚文,刘红,吴静.胃黏膜保护机制与药物研究进展[J].临床药物治疗杂志,2018,16(10):8-12.
|
[42] |
周晓平,钟柏松.铝碳酸镁药理研究进展及临床应用[J].西北药学,2001,16(4):183-186.
|
[43] |
史一杰.瑞巴派特纳米制剂及其黏膜保护作用的研究[D].沈阳:沈阳药科大学,2012.
|
[44] |
张文义.中西医结合论治胃肠病[J].中医临床研究,2017,9(30):65-67.
|
[45] |
唐蕾.中西医结合治疗胃肠疾病的思路与方法[J].中医药管理杂志,2014,22(13):2282-2283.
|
[46] |
马玉帛,李婷宇,曹海超,等.粪菌移植的临床研究进展[J].中华消化病与影像杂志(电子版),2016,6(1):28-35.
|
[47] |
曾祥宇,陶凯雄.粪菌移植的研究进展[J].国际消化病杂志,2017,37(1):34-37.
|